BRIEF published on 03/21/2024 at 09:35, 1 year 8 months ago Dr. Wiktor Patena Takes Helm at GBSB Global Business School Higher Education Educational Innovation GBSB Global Business School Dr. Wiktor Patena International Accreditation
BRIEF published on 03/21/2024 at 09:35, 1 year 8 months ago Le Dr Wiktor Patena prend la tête de la GBSB Global Business School L'enseignement Supérieur Innovation Pédagogique École De Commerce Mondiale GBSB Dr Wiktor Patena Accréditation Internationale
PRESS RELEASE published on 03/21/2024 at 09:30, 1 year 8 months ago Dr. Wiktor Patena assumes the executive leadership of GBSB Global, ushering in a new era of educational excellence GBSB Global Business School appoints Dr. Wiktor Patena as the new Head of Institution and President to lead strategic improvements and academic expansion GBSB Global Business School Dr. Wiktor Patena Higher Education Institution Academic Expansion Strategic Improvements
Published on 12/05/2025 at 02:35, 4 hours 45 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 20 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 15 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 20 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 20 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 50 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 29 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 55 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 5 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 5 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 20 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 20 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 35 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 35 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
